| ²é¿´: 2728 | »Ø¸´: 18 | |||
[½»Á÷]
ÃÀ¹úÕÐÆ¸ÓлúºÏ³É²©ºóÒ»Ãû
|
|||
|
´ó¼ÒºÃ£¬ÈÏʶµÄһλÀÏʦ¸ÕÄõ½Ò»±Ê¾·Ñ£¬ÐèÒªÕÐÆ¸Óлú»¯Ñ§·½ÏòµÄ²©ºóÒ»Ãû£¬¾ßÌåÒªÇóÈçÏ£¬ËûûÓÐдÃ÷¹¤×Ê£¬´ó¼Ò¿ÉÒÔÖ±½ÓÎÊ£¬µ«Ó¦¸Ã²»»áµÍÓÚ40KÒ»Äꡣлл´ó¼Ò¡£ The NIH-RCMI Cancer Research Center is seeking to fill a Ph.D. level Research Associate position to conduct medicinal chemistry research under the direction of Professor Guangdi Wang, principal investigator and program director of the RCMI Cancer Research Center. The responsibilities of the position include rational design, synthesis, and structure-activity relationship studies in support of the oncology drug discovery program in Dr. Wang¡¯s laboratory at the Xavier University of Louisiana. A Ph.D. in medicinal chemistry or related field and a minimum of two years of laboratory experience in medicinal chemistry are required. Contact: gwang@xula.edu; zwang@xula.edu |
» ²ÂÄãϲ»¶
»¶ÓÉ격ͬѧÁªÏµ
ÒѾÓÐ7È˻ظ´
¶«ÄÏ´óѧ364Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
326Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
»¯Ñ§¹¤³Ì321·ÖÇóµ÷¼Á
ÒѾÓÐ5È˻ظ´
²ÄÁϹ¤³Ìר˶274Ò»Ö¾Ô¸211Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
311Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
Ò»Ö¾Ô¸985£¬±¾¿Æ211£¬0817»¯Ñ§¹¤³ÌÓë¼¼Êõ319Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
0703»¯Ñ§µ÷¼Á £¬Áù¼¶Òѹý£¬ÓпÆÑоÀú
ÒѾÓÐ4È˻ظ´
321Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
0703 ÎïÀí»¯Ñ§µ÷¼Á
ÒѾÓÐ3È˻ظ´
» ÇÀ½ð±ÒÀ²£¡»ØÌû¾Í¿ÉÒԵõ½:
»¯Ñ§»¯¹¤Ñ§Ôº ÕÐÊÕ»¯¹¤¡¢»¯Ñ§¡¢²ÄÁϵÈÏà¹Ø·½ÏòÑо¿Éú£¨Ñ§Ë¶¡¢×¨Ë¶¶¼Óе÷¼ÁÃû¶î£©
+1/83
¸£½¨Ê¦·¶´óѧÕÐÊÕ2026Ä껯ѧ¡¢²ÄÁÏ˶ʿ3-4Ãû
+1/83
º£ÄÏ´óѧФÓÀê»ÀÏʦÍŶÓÕÐÊÕ2026Ä격ʿÑо¿Éú£¨µÚ¶þÅú£©
+5/40
¼ÓÄô󰢶û²®Ëþ´óѧÕÐÊÕµç´Å¡¢ÎÞÏßͨÐÅ¡¢»úÆ÷ѧϰ·½ÏòÈ«½±Ë¶Ê¿/²©Ê¿/²©Ê¿ºó/·ÃÎÊѧÕß
+2/24
ÏÃÃÅ´óѧº½¿Õº½ÌìѧԺÖÇÄÜÖÆÔì¿ÎÌâ×éÕÐ2026ÄêÉêÇëÉóºËÖÆ²©Ê¿Éú1Ãû
+1/22
¡¾2026²©Ê¿ÕÐÉú/²©ºóÕÐÆ¸¡¿±±¾©º½¿Õº½Ìì´óѧÅ˱ë¿ÎÌâ×顪¡ªAIоƬÉè¼Æ·½Ïò
+1/17
ҽѧ327·Öר˶µ÷¼Á
+1/16
ÉϺ£½»Í¨´óѧҩѧԺ¸ßÑî¿ÎÌâ×é³ÏƸ²©Ê¿ºó
+1/14
Çൺ¿Æ¼¼´óѧ0860 µ÷¼ÁÕÐÉú
+1/13
Î÷¾©Ñ§ÔºÍÁľˮÀû 2026 ¼¶Ñо¿ÉúÕÐÉúÏà¹ØËµÃ÷
+1/8
ʳƷ¿ÆÑ§Ó빤³Ì083200-297·Ö
+1/8
²©Ê¿ºóÕÐÆ¸£¨¸ßн40Íò+£©
+1/8
Ïã¸ÛÖÐÎÄ´óѧ£¨ÉîÛÚ£©¹Ü¾ý¿ÎÌâ×é ΢Äɹâѧ·½Ïò ÕÐÊÕ˶ʿ¡¢²©Ê¿¡¢²©Ê¿ºó
+1/6
¡¾µÚÈýÂÖÕÐÉú£¬31ºÅ½ØÖ¹¡¿°Ä¿Æ´ó³ÏÕÐ2026ÇïÈ«½±²©Ê¿Ñо¿Éú£¨ÄÉÃ×ҽѧ/ÉúÎï²ÄÁÏ·½Ïò£©
+1/6
¸ßУÕÐÆ¸
+1/3
ºþÄÏ´óѧ2026²©Ê¿ÕÐÉú-È˹¤ÖÇÄܰ²È«·½Ïò
+1/3
ÄϾ©Ò½¿Æ´óѧ-Ĥµ°°×½á¹¹Ó빦ÄÜ¿ÎÌâ×é-ÕÐÊÕ2026¼¶²©Ê¿Ñо¿Éú
+1/3
ÕÐÊÕÀíÂÛÄý¾Û̬ÎïÀí/ÄÉÃ×¹âѧ/Á¿×Ó¼ÆËã·½Ïò²©Ê¿¡¢Ë¶Ê¿Ñо¿Éú/²©Ê¿ºó
+1/2
²ãÁ÷ѹ²îʽÁ÷Á¿²â¿Ø²úÆ·ÔÚ´óÆøÔËά²ÉÑùÁ÷Á¿Ð£×¼ÖеÄÓ¦ÓÃÓëÓÅÊÆ
+1/1
Ò»Ö¾Ô¸Ç廪²ÄÁÏÓ뻯¹¤£¨0856£©325 ·Ö£¬±¾¿ÆË«Ò»Á÷ÉúÎ﹤³Ì£¬³ÏÇóµ÷¼Á
+1/1
2Â¥2019-04-15 08:13:49
9Â¥2019-04-16 14:23:16
14Â¥2019-04-19 21:26:14
15Â¥2019-05-01 03:21:02
16Â¥2019-05-01 07:35:33
18Â¥2019-06-28 21:33:10
19Â¥2019-07-05 20:04:10
¼òµ¥»Ø¸´
youngen3Â¥
2019-04-15 08:20
»Ø¸´
sunshine444Â¥
2019-04-15 08:29
»Ø¸´
h569662697(½ð±Ò+1): лл²ÎÓë
£¬ ·¢×ÔСľ³æIOS¿Í»§¶Ë
Cherry04135Â¥
2019-04-15 08:37
»Ø¸´
h569662697(½ð±Ò+1): лл²ÎÓë
, ·¢×ÔСľ³æAndroid¿Í»§¶Ë
159413916676Â¥
2019-04-15 09:10
»Ø¸´
h569662697(½ð±Ò+1): лл²ÎÓë
pxy847Â¥
2019-04-15 09:58
»Ø¸´
h569662697(½ð±Ò+1): лл²ÎÓë
miaojiabing8Â¥
2019-04-15 15:38
»Ø¸´
h569662697(½ð±Ò+1): лл²ÎÓë
СÓã·ç10Â¥
2019-04-18 20:59
»Ø¸´
fxianlei11Â¥
2019-04-19 09:53
»Ø¸´
h569662697(½ð±Ò+1): лл²ÎÓë
158616553212Â¥
2019-04-19 15:03
»Ø¸´
h569662697(½ð±Ò+1): лл²ÎÓë
nono200913Â¥
2019-04-19 21:17
»Ø¸´
h569662697(½ð±Ò+1): лл²ÎÓë
¡¤
Graphener17Â¥
2019-06-15 10:16
»Ø¸´
h569662697(½ð±Ò+1): лл²ÎÓë
¡£ ·¢×ÔСľ³æAndroid¿Í»§¶Ë













»Ø¸´´ËÂ¥
